205 related articles for article (PubMed ID: 30722718)
21. One-Year Results of First-Line Treatment Strategies in Patients With Critical Limb Ischemia (CRITISCH Registry).
Stavroulakis K; Borowski M; Torsello G; Bisdas T;
J Endovasc Ther; 2018 Jun; 25(3):320-329. PubMed ID: 29968501
[TBL] [Abstract][Full Text] [Related]
22. Outcomes of Drug-Coated Balloon Angioplasty vs. Conventional Balloon Angioplasty for Endovascular Treatment of Common Femoral Artery Atherosclerotic Disease.
Cantu D; Jawaid O; Kokkinidis D; Giannopoulos S; Valle JA; Waldo SW; Singh GD; Armstrong EJ
Cardiovasc Revasc Med; 2020 Jul; 21(7):867-874. PubMed ID: 31761636
[TBL] [Abstract][Full Text] [Related]
23. Contemporary management of critical lower limb ischemia in TASC D lesions with subintimal angioplasty in femoro-popliteal lesions, tibial angioplasty and sequential compression biomechanical device for infra-inguinal arterial occlusion. Experience and quality of life outcome learned over 25 years.
Sultan S; Hynes N
J Cardiovasc Surg (Torino); 2014 Dec; 55(6):813-25. PubMed ID: 25216216
[TBL] [Abstract][Full Text] [Related]
24. Impact of endovascular options on lower extremity revascularization in young patients.
Chaar CI; Makaroun MS; Marone LK; Rhee RY; Al-Khoury G; Cho JS; Leers SA; Chaer RA
J Vasc Surg; 2012 Sep; 56(3):703-13.e1-3. PubMed ID: 22579133
[TBL] [Abstract][Full Text] [Related]
25. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
Torsello G; Stavroulakis K; Brodmann M; Micari A; Tepe G; Veroux P; Benko A; Choi D; Vermassen FEG; Jaff MR; Guo J; Dobranszki R; Zeller T;
J Endovasc Ther; 2020 Oct; 27(5):693-705. PubMed ID: 32583749
[No Abstract] [Full Text] [Related]
26. Amputation-free survival, limb symptom alleviation, and reintervention rates after open and endovascular revascularization of femoropopliteal lesions in patients with chronic limb-threatening ischemia.
Perlander A; Jivegård L; Nordanstig J; Svensson M; Österberg K
J Vasc Surg; 2020 Dec; 72(6):1987-1995. PubMed ID: 32276010
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and Safety of a Paclitaxel-Eluting Stent for Superficial Femoral Artery Lesions up to 190 mm: One-Year Outcomes of the Single-Arm IMPERIAL Long Lesion Substudy of the Eluvia Drug-Eluting Stent.
Golzar J; Soga Y; Babaev A; Iida O; Kawasaki D; Bachinsky W; Park J; Prem JT; Vermassen F; Diaz-Cartelle J; Müller-Hülsbeck S; Gray WA
J Endovasc Ther; 2020 Apr; 27(2):296-303. PubMed ID: 31989856
[No Abstract] [Full Text] [Related]
28. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
29. Prospective Single-Arm Trial of Endovascular Mechanical Debulking as Initial Therapy in Patients With Acute and Subacute Lower Limb Ischemia: One-Year Outcomes.
Bulvas M; Sommerová Z; Vaněk I; Weiss J
J Endovasc Ther; 2019 Jun; 26(3):291-301. PubMed ID: 30955402
[TBL] [Abstract][Full Text] [Related]
30. Anterior, posterior, or all-vessel infrapopliteal revascularization in patients with moderate-severe claudication: Insights from the LIBERTY 360 study.
Salahuddin T; Giannopoulos S; Adams G; Armstrong EJ
Catheter Cardiovasc Interv; 2021 Sep; 98(3):559-569. PubMed ID: 34057276
[TBL] [Abstract][Full Text] [Related]
31. Editor's Choice - Dual Antiplatelet Therapy Improves Outcome in Diabetic Patients Undergoing Endovascular Femoropopliteal Stenting for Critical Limb Ischaemia.
Thott O; Granath F; Malmstedt J; Wahlgren CM
Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):403-410. PubMed ID: 28131536
[TBL] [Abstract][Full Text] [Related]
32. Endovascular treatment of TransAtlantic Inter-Society Consensus II D femoropopliteal lesions in patients with critical limb ischemia.
Biagioni RB; Brandão GD; Biagioni LC; Nasser F; Burihan MC; Ingrund JC
J Vasc Surg; 2019 May; 69(5):1510-1518. PubMed ID: 30611581
[TBL] [Abstract][Full Text] [Related]
33. One-Year Outcomes of the Paclitaxel-Eluting, Self-Expanding Stentys Stent System in the Treatment of Infrapopliteal Lesions in Patients With Critical Limb Ischemia.
Bosiers M; Callaert J; Keirse K; Hendriks JMH; Peeters P; Verbist J; Maene L; Beelen R; Deloose K
J Endovasc Ther; 2017 Jun; 24(3):311-316. PubMed ID: 28351310
[TBL] [Abstract][Full Text] [Related]
34. Six-Month Freedom From Amputation Rates and Quality of Life Following Tibial and Pedal Endovascular Revascularization for Critical Limb Ischemia.
Dua A; Rothenberg KA; Lee JJ; Gologorsky R; Desai SS
Vasc Endovascular Surg; 2019 Apr; 53(3):212-215. PubMed ID: 30618346
[TBL] [Abstract][Full Text] [Related]
35. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons.
Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K
Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for adverse outcomes after endovascular therapy for critical limb ischemia with tissue loss due to infrainguinal artery disease.
Tnishibe T; Yamamoto K; Toguchi K; Seike Y; Ito N; Nishibe M; Koizumi J; Dardik A; Ogino H
Int Angiol; 2016 Oct; 35(5):477-83. PubMed ID: 26344514
[TBL] [Abstract][Full Text] [Related]
37. Impact of impaired ambulatory capacity on the outcomes of peripheral vascular interventions among patients with chronic limb-threating ischemia.
Naazie IN; Arhuidese I; Zil-E-Ali A; Siracuse JJ; Malas MB
J Vasc Surg; 2021 Aug; 74(2):489-498.e1. PubMed ID: 33548441
[TBL] [Abstract][Full Text] [Related]
38. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia.
Darling JD; McCallum JC; Soden PA; Meng Y; Wyers MC; Hamdan AD; Verhagen HJ; Schermerhorn ML
J Vasc Surg; 2016 Sep; 64(3):616-22. PubMed ID: 27380993
[TBL] [Abstract][Full Text] [Related]
39. Peroneal bypass versus endovascular peroneal intervention for critical limb ischemia.
Mohapatra A; Boitet A; Malak O; Henry JC; Avgerinos ED; Makaroun MS; Hager ES; Chaer RA
J Vasc Surg; 2019 Jan; 69(1):148-155. PubMed ID: 30580779
[TBL] [Abstract][Full Text] [Related]
40. Retrograde Pedal Access and Endovascular Revascularization: A Safe and Effective Technique for High-Risk Patients with Complex Tibial Vessel Disease.
El-Sayed H; Bennett ME; Loh TM; Davies MG
Ann Vasc Surg; 2016 Feb; 31():91-8. PubMed ID: 26627317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
